Great Debates and Updates in Breast Cancer

Imedex, LLC
Last Modified: February 13, 2009

Conference Dates: June 19-20, 2009
Conference Location: San Francisco, CA

Sponsoring Group: Imedex, LLC

Conference Web Page URL:

Topics Covered:

  • Chemoprevention of breast cancer
  • Selecting techniques for breast cancer surgery
  • Confusion and controversies in radiation therapy
  • Integration of bisphosphonates into adjuvant therapy regimens for early breast cancer
  • Clinical updates in translational science
  • Interpretation and integration of recent clinical trial data into clinical practice
  • Pharmacogenomics and effects on drug interactions, efficacy and safety
  • Combinations of hormonal and biologic agents
  • Appropriate use of anthracyclines in early breast cancer
  • Treatment of pre- and-postmenopausal women with hormone receptor-positive breast cancer
  • Management of patients with relapsed HER2-positive breast cancer
  • Potential role for EGFR targeted therapy in breast cancer
  • Novel cytotoxic agents for breast cancer
  • Management of triple negative/basal type breast cancer
  • Monitoring and managing the cardiotoxicity of systemic therapeutic agents
  • Optimal use of lapatinib in patients with HER2-positive metastatic breast cancer
  • Mechanisms and management of trastuzumab resistance

Conference Objectives: Great Debates and Updates in Breast Cancer will be a world class medical education forum for the exchange of critical information in the field of breast cancer. It features didactic presentations and a debate format, in which distinguished faculty discuss some of the most challenging topics in breast cancer.

Who Should Attend: Medical Oncologists, Radiation Oncologists, Surgical Oncologists, Nurses, Fellows, and Residents.

Conference Agenda:

Registration Information: To pre-register, registration and payment must be received no later than June 11, 2009. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at to ensure that the program is being held as scheduled and to confirm that the meeting is not full.

Conference Fees: $75 - $150

Continuing Education: Yes

Related News

Limited Evidence for Screening Mammography for Women in 40s

Jun 4, 2015

But conclusion wasn't unanimous, one expert says

Guidance Updated for Sentinel Node Biopsy in Breast Cancer

Mar 27, 2014

ASCO updates its 2005 guideline for use of sentinel node biopsy in early breast cancer

RSNA: Risk-Based Screens May Miss Too Many Breast Cancers

Dec 4, 2014

Limiting mammography to women with family history, dense breasts would miss many cancers